MedTrace Logo

Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT

NCT00428129 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2014-04-07

No results posted yet for this study

Summary

A single centre, single-arm study to evaluate safety and efficacy of microplasmin administration via the Trellis-8 Infusion System in patients with acute iliofemoral DVT

Conditions

  • Deep Vein Thrombosis

Interventions

DRUG

microplasmin

20mg with Trellis-8 15cm Treatment length 40mg with Trellis-8 30cm Treatment length

Sponsors & Collaborators

  • Bacchus Vascular

    collaborator INDUSTRY

  • ThromboGenics

    lead INDUSTRY

Principal Investigators

  • Gerard O'Sullivan, MD · Section of Interventional Radiology, Department of Radiology, University College Hospital, Newcastle Road, Galway

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2008-07-31
Completion
2008-10-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00428129 on ClinicalTrials.gov